Two functions – complementary, but different
Pharmaceutical companies rely on their Medical Affairs and Commercial functions to give healthcare professionals the best understanding of their products. Roles in both functions depend on core knowledge of therapy area, disease state, product characteristics and market. But the depth of the required knowledge, and how it can be used, is a key differentiator. Commercial teams promote products – Medical Affairs teams must not.
That means training curricula and content for field sales representatives typically focus on licensed uses, clinical benefits, safety information and prescribing details within the relevant promotional rules. Reps need scientific confidence, communication skills, product knowledge and the judgement to stay within approved claims.
Medical Affairs has a different mandate – to enable credible, evidence-based scientific exchange. Medical Science Liaisons (MSLs) engage with clinicians and scientific experts on clinical practice, unmet needs and emerging research. They generally need deep understanding of areas like trial methodology, data interpretation and therapeutic landscapes.
With a common foundation of knowledge underpinning both functions, there’s clear opportunity to achieve consistency and efficiency with training resources – build a single core of training content which can then be adapted and extended as needed to suit the needs of each audience. But while it may seem obvious, there are significant practical barriers that make it hard to do.
When function drives fragmentation
The promotional/non-promotional divide is a structural reality for pharmaceutical companies. Commercial and Medical Affairs are separate functions, often with specific ‘firewalls’ between them to prevent inadvertent infringement of regulations governing product promotion. This separation is made for good reason, but it can result in training efforts becoming fragmented.
Often, Medical and Commercial training is achieved through separate budgets, teams, agencies and approval processes. Timelines are separate too, with medical training typically developed during clinical development, whereas commercial curricula are more likely to be created as the product nears approval. Each team might build resources like disease-state modules, mechanism-of-action explainers, trial summaries and knowledge checks, without knowing that similar content already exists.
The practical consequences of this separation are duplication of effort – in writing, design, expert review, and localisation. That means increased cost and higher demand on the time of busy subject matter experts. It also risks inconsistency across what should be common messages.
Acteon’s deep experience supporting the training needs of Medical and Commercial teams in global pharmaceutical companies means we’re very familiar with these challenges. With training budgets under increasing scrutiny, we’re working to help our clients avoid duplicating effort and wasting precious resources. So let's look at four key barriers to achieving consistency and efficiency with training efforts, and consider how they can be overcome with solutions that respect the necessary differences between these essential functions.
Four barriers to aligning Medical and Commercial training
Barrier 1. Learning needs are different
MSLs typically come with advanced scientific or clinical qualifications, and their role requires them to critique evidence, discuss study limitations and respond to sophisticated questions from clinical practitioners. Sales representatives come from a wider range of backgrounds. They still need accurate scientific understanding, but will usually benefit from clearer structure and signposting, more essential terminology and disease fundamentals, and deeper explanation of how evidence supports approved product messages.
We’ve found that two early and related interventions result in the most efficient and effective ways to meet these different needs:
Taking a modular approach to content development and differentiating between material that can be consistently applied across Medical and Commercial teams, and material that addresses distinct functional needs. For example, core content in patient experience or clinical data might be augmented by preliminary training pieces specifically for sales representatives, and additional deep-dive content for MSLs in areas like trial design, endpoints, subgroup analyses and evolving scientific questions.
Differentiating between ‘foundation’ and ‘application’. Both sales representatives and MSLs need to build foundational knowledge – like disease biology, patient pathways, product characteristics and safety. But how they apply that knowledge, and what they are trying to achieve, differ. The design and content of application exercises, like role plays or simulations, can reflect those differences while building on shared foundational content. So reps might practise explaining an approved benefit-risk profile accurately, where MSLs might critically appraise the same study and discuss its limitations.
The efficiency comes from reusing scientific assets but tailoring the training experience. One fully referenced explanation of a disease pathway can support multiple modules, without requiring every learner to follow the same path.
Barrier 2. Different boundaries for scientific communication
The second challenge is not simply that MSLs can discuss more topics than sales representatives. It is that the purpose, context and conditions of that communication matter. While sales representatives can only talk about information contained in the approved product label, MSLs have greater flexibility to discuss trial details, competitors and disease information.
Again, a modular approach, with differentiation between foundation and application content is valuable. A shared scientific core can be developed alongside role-specific modules on communication rules, escalation routes and unsolicited requests, reinforced with practical scenarios. Content can be access-controlled where necessary, so sales reps are not exposed to content that they’re not allowed to discuss.
This is an area where scenario-based application exercises are especially helpful for meeting the different functional needs. What should a representative do if they’re asked about an unapproved indication? How should an MSL respond to an unsolicited scientific enquiry? Where does a conversation need to be referred to Medical Information? Practising making these decisions builds compliance more effectively than just relying on disclaimers stated in the core content.
Barrier 3. Poor visibility of existing training
This third barrier is organisational rather than content-related. We’ve already described the necessary separation of Medical and Commercial functions in pharmaceutical companies. Where this leads to training teams working autonomously, they may not know when modules, animations, workshops or assessments have already been commissioned. And even where materials exist within a corporate learning management system, they may be difficult to find, described inconsistently or inaccessible to other functions. The result is a cycle that might be familiar: a new request is raised, an agency is briefed and an asset is rebuilt because reuse was never considered.
How do you break the cycle?
Early alignment of Medical and Commercial training teams, integrated as part of launch excellence, means shared decisions can be made about what foundational, application and sustainment content has already been developed by the Medical team, what additional content is required to support product launch, and who is responsible for commissioning it. The result can be a shared roadmap for the development of foundational content, with each function having clarity and ownership for the specific training needs of its own audience.
Increased visibility of existing content and development plans. Despite the aspiration described above, it will often be the case that product launch is well advanced without a cross-functional roadmap for the development of training content. Here, as in so many situations, the answer is improved communication. Training teams can provide cross functional updates on the current curricula, new assets and upcoming needs. The Commercial training team in a client of ours has recently started publishing a monthly newsletter sharing details of new assets and content in development.
Barrier 4. Different evidence and referencing requirements
A fourth barrier emerges when training content that’s acceptable for one audience is adapted for another. Training for MSLs may draw on internal analyses, data on file, congress abstracts, unpublished findings and other competitive intelligence, whilst acceptable sources for Commercial materials are typically restricted to product labels, journal papers, conference presentations, textbooks and government/international organisation websites. Precise rules vary depending on jurisdiction, content and intended use, but it’s not safe to assume that a source that’s acceptable for appropriate scientific exchange will therefore support an external promotional claim.
This barrier is another that’s most easily overcome through alignment of Medical and Commercial training needs. Medical training is developed earlier in the product lifecycle than Commercial, typically during clinical development. If a siloed approach is taken, then training content referenced to the broader standards required for Medical content may need substantial rework, or be altogether unusable, for Commercial training.
Whereas, with early alignment, foundational content can be developed following the stricter referencing standards required for Commercial materials, making it usable for both audiences. This won’t always be possible, of course, so this is another area where taking a modular approach pays dividends. Content that is only appropriate for MSLs can be separated into distinct assets and referenced accordingly.
Working towards a shared training infrastructure
Let’s imagine these four solutions working as part of an aligned end-to-end process. It would begin with a cross-functional map of the capabilities needed for each role, and an inventory of existing training content. This would support a learning design exercise to establish content which can be genuinely shared, content which needs to provide different levels of depth, and content which must remain separate because of purpose or compliance. This can form the inventory of a common content library, comprising modular components, each with the necessary metadata to make sure it is used appropriately.
That’s an aspirational vision, and probably hard to achieve for most companies, given where they’re starting from. But even as an aspiration, it can inform local decision-making and help drive greater alignment between Medical and Commercial training teams. Recognition of shared training needs, differentiating between foundation and application, using a modular approach to separate content of different depth or purpose, and increasing the visibility of what is being developed, all help to promote the efficiency and effectiveness of training efforts.
We’re helping Medical and Commercial training teams recognise that they don’t need to choose between either completely separate training programmes or a risky compromise with shared materials. The two functions are complimentary, but different, and the training they provide can be too. It is possible to achieve consistency and efficiency whilst respecting the distinct purpose that each delivers.
Talk to us about aligning your Medical and Commercial Training content.